Regulatory Consulting and FDA Submission Support

The contract involves providing strategic regulatory planning and submission support services specifically tailored for New Drug Application (NDA), supplemental New Drug Application (sNDA), or Biologics License Application (BLA) filings related to antifungal medical countermeasures. The focus is on guiding and assisting with the complex regulatory requirements necessary for successful FDA submissions in this specialized medical field. Issued by the Department of Health and Human Services under the BARDA division, the opportunity is classified under NAICS code 541611, which pertains to administrative management and general consulting services. It is structured as a subcontract, with the response deadline set for June 21, 2026. Performance location details are not specified, and there is no indication of set-aside status. The contract aims to leverage expert regulatory consulting to facilitate the development and approval of critical antifungal therapies intended for medical countermeasure use.